Individualized recombinant human thrombomodulin (ART-123) administration in sepsis patients based on predicted phenotypes

Detalles Bibliográficos
Autores principales: Hasegawa, Daisuke, Nishida, Osamu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6591969/
https://www.ncbi.nlm.nih.gov/pubmed/31234901
http://dx.doi.org/10.1186/s13054-019-2521-7
_version_ 1783429817990905856
author Hasegawa, Daisuke
Nishida, Osamu
author_facet Hasegawa, Daisuke
Nishida, Osamu
author_sort Hasegawa, Daisuke
collection PubMed
description
format Online
Article
Text
id pubmed-6591969
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-65919692019-07-08 Individualized recombinant human thrombomodulin (ART-123) administration in sepsis patients based on predicted phenotypes Hasegawa, Daisuke Nishida, Osamu Crit Care Letter BioMed Central 2019-06-24 /pmc/articles/PMC6591969/ /pubmed/31234901 http://dx.doi.org/10.1186/s13054-019-2521-7 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Letter
Hasegawa, Daisuke
Nishida, Osamu
Individualized recombinant human thrombomodulin (ART-123) administration in sepsis patients based on predicted phenotypes
title Individualized recombinant human thrombomodulin (ART-123) administration in sepsis patients based on predicted phenotypes
title_full Individualized recombinant human thrombomodulin (ART-123) administration in sepsis patients based on predicted phenotypes
title_fullStr Individualized recombinant human thrombomodulin (ART-123) administration in sepsis patients based on predicted phenotypes
title_full_unstemmed Individualized recombinant human thrombomodulin (ART-123) administration in sepsis patients based on predicted phenotypes
title_short Individualized recombinant human thrombomodulin (ART-123) administration in sepsis patients based on predicted phenotypes
title_sort individualized recombinant human thrombomodulin (art-123) administration in sepsis patients based on predicted phenotypes
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6591969/
https://www.ncbi.nlm.nih.gov/pubmed/31234901
http://dx.doi.org/10.1186/s13054-019-2521-7
work_keys_str_mv AT hasegawadaisuke individualizedrecombinanthumanthrombomodulinart123administrationinsepsispatientsbasedonpredictedphenotypes
AT nishidaosamu individualizedrecombinanthumanthrombomodulinart123administrationinsepsispatientsbasedonpredictedphenotypes

Ejemplares similares